Confronta i metodi
Esamina i metodi selezionati fianco a fianco; le righe che differiscono sono evidenziate.
| Modellizzazione Farmacodinamica di Popolazione× | Cinetica di Michaelis-Menten× | |
|---|---|---|
| Campo | Farmacologia | Farmacologia |
| Famiglia | Process / pipeline | Process / pipeline |
| Anno di origine≠ | 1992 | 1913 |
| Ideatore≠ | Lewis Sheiner and Stephen Roush | Leonor Michaelis and Maud Menten |
| Tipo≠ | dose-response modeling | mechanistic model |
| Fonte seminale≠ | Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗ | Michaelis, L., & Menten, M. L. (1913). Die Kinetik der Invertinwirkung. Biochemische Zeitschrift, 49, 333-369. link ↗ |
| Alias | PopPD, population PD, hierarchical PD modeling | MM kinetics, Michaelis constant, Vmax |
| Correlati≠ | 3 | 2 |
| Sintesi≠ | Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction. | Michaelis-Menten kinetics describes the rate of enzyme-catalyzed reactions as a function of substrate concentration. Developed by Leonor Michaelis and Maud Menten in 1913, this foundational framework models enzyme catalysis through the rapid-equilibrium approximation and enables prediction of drug metabolism rates in pharmacokinetics. |
| ScholarGateInsieme di dati ↗ |
|
|